Abstract
Vagus nerve stimulation (VNS) is the most widely used non-pharmacological treatment for medically intractable epilepsy and has been in clinical use for over a decade. It is indicated in patients who are refractory to medical treatment or who experience intolerable side effects, and who are not candidates for resective surgery. VNS used in the acute setting can both abort seizures and have an acute prophylactic effect. This effect increases over time in chronic treatment to a maximum at around 18 months. The evidence base supporting the efficacy of VNS is strong, but its exact mechanism of action remains unknown. A vagus nerve stimulator consists of two electrodes embedded in a silastic helix that is wrapped around the cervical vagus nerve. The stimulator is always implanted on the left vagus nerve in order to reduce the likelihood of adverse cardiac effects. The electrodes are connected to an implantable pulse generator (IPG) which is positioned subcutaneously either below the clavicle or in the axilla. The IPG is programmed by computer via a wand placed on the skin over it. In addition, extra pulses of stimulation triggered by a hand-held magnet may help to prevent or abort seizures. VNS is essentially a palliative treatment and the number of patients who become seizure free is very small. A significant reduction in the frequency and severity of seizures can be expected in about one third of patients and efficacy tends to improve with time. Vagus nerve stimulation is well tolerated and has few significant side effects. We describe our experience on the use of VNS on drug-resistant epilepsy in 90 patients treated in two departments (in Athens, Greece and Newcastle, England).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bailey P, Bremer F (1938) A sensory cortical representation of the vagus nerve. J Neurophysiol 1: 405–412
Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA (1999) Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci 2: 94–98
Espinosa J, Aiello MT, Naritoku DK (1999) Revision and removal of stimulating electrodes following long-term therapy with the vagus nerve stimulator. Surg Neurol 51: 659–664
Gatzonis SD, Stamboulis E, Siafakas A, Angelopoulos E, Georgaculias N, Singounas E, Jenkins (2000) Acute psychosis and EEG normalization after vagus nerve stimulation. J Neurol Neurosurg Psychiatry 69: 278–279
Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW (1998) Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 51: 48–55
Labar D, Murphy J, Tecoma E (1999) Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 Study Group. Neurology 52: 1510–1512
Labar D, Nikolov B, Tarver B, Fraser R (1998) Vagus nerve stimulation for symptomatic generalized epilepsy: a pilot study. Epilepsia 39: 201–205
Lundgren J, Amark P, Blennow G, Stromblad LG, Wallstedt L (1998) Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia 39: 809–813
Lundgren J, Ekberg O, Olsson R (1998) Aspiration: a potential complication to vagus nerve stimulation. Epilepsia 39: 998–1000
McLachlan RS (1993) Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia 34: 918–923
Murphy JV (1999) Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group. J Pediatr 134: 563–566
Naritoku DK, Morales A, Pencek TL, Winkler D (1992) Chronic vagus nerve stimulation increases the latency of the thalamocortical somatosensory evoked potential. Pacing Clin Electrophysiol 15: 1572–1578
Parent A, Carpenter M (1996) Carpenter’s human neuroanatomy, 9th edn. Williams & Wilkins, Baltimore, p 1011
Penry JK, Dean JC (1990) Prevention of intractable partial seizures by intermittent stimulation in humans: preliminary results. Epilepsia 31Suppl 2: S40–S43
Rutecki P (1990) Anatomical, physiological and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia 31Suppl 2: S1–S6
Stabulis E, Catsaros N, Gatzonis S, Siafakas A, Georgaculias N, Sakas D (2005) Cardiac vagal tests and vagus nerve stimulation in epilepsy. Clin Auton Res 15: 54–56
The Vagus Nerve Stimulation Study Group (1995) A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizure. Neurology 45: 224–230
Woodbury JW, Woodbury DM(1991) Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording. Pacing Clin Electrophysiol 14: 94–107
Yoshor D, Barbaro N (2003) Palliative Surgery for Epilepsy: Corpus Callosotomy and Vagus Nerve Stimulation. In: Batjer H, Loftus C (eds) Textbook of neurological surgery: principles and practices. Lippincott Williams & Wilkins, Baltimore, pp 2748–2754
Zabara L (1985) Peripheral control of hypersynchronous discharge in epilepsy. Electoencephalogr Clin Neurophysiol 61: 162
Zabara J (1992) Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 33: 1005–1012
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag
About this chapter
Cite this chapter
Sakas, D.E. et al. (2007). Vagus nerve stimulation for intractable epilepsy: outcome in two series combining 90 patients. In: Sakas, D.E., Simpson, B.A. (eds) Operative Neuromodulation. Acta Neurochirurgica Supplements, vol 97/2. Springer, Vienna. https://doi.org/10.1007/978-3-211-33081-4_32
Download citation
DOI: https://doi.org/10.1007/978-3-211-33081-4_32
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-33080-7
Online ISBN: 978-3-211-33081-4
eBook Packages: MedicineMedicine (R0)